{"url_path":"/sec/scnx/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 EXHIBITS**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1382574/0001493152-26-023862-index.html","accession_number":"0001493152-26-023862","cik":"0001382574","ticker":"SCNX","issuer_name":"Scienture Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1382574/0001493152-26-023862-index.html","primary_entity_key":"0001382574","primary_entity_name":"Scienture Holdings, Inc."},"word_count":833,"has_tables":true,"body_markdown":"**ITEM\n6. EXHIBITS**\n\n \n\n**Exhibit\nNo.**\n \n**Description**\n\n3.1\n \n[Second Amended and Restated Certificate of Incorporation of the Company, as amended through September 20, 2024 (incorporated by reference to Exhibit 3.1 of the Company’s Form 10-K filed on March 26, 2025).](https://www.sec.gov/Archives/edgar/data/1382574/000149315219015539/ex3-1.htm)\n\n3.2\n \n[Certificate of Amendment to Second Amended and Restated Certificate of Incorporation (1-for-6 Reverse Stock Split of Common Stock) filed with the Delaware Secretary of State on February 12, 2020, and effective February 13, 2020 (incorporated by reference to Exhibit 3.3 of the Company’s Form 10-K filed on March 26, 2025).](https://www.sec.gov/Archives/edgar/data/1382574/000149315220002168/ex3-1.htm)\n\n3.3\n \n[Certificate of Amendment of Certificate of Incorporation (changing name TRxADE HEALTH, INC.) (incorporated by reference to Exhibit 3.4 of the Company’s Form 10-K filed on March 26, 2025).](https://www.sec.gov/Archives/edgar/data/1382574/000149315221013215/ex3-1.htm)\n\n3.4\n \n[Form of Certificate of Amendment to Second Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.5 of the Company’s Form 10-K filed on March 26, 2025).](https://www.sec.gov/Archives/edgar/data/1382574/000149315223021489/ex3-1.htm)\n\n3.5\n \n[Certificate of Amendment of Second Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.6 of the Company’s Form 10-K filed on March 26, 2025).](https://www.sec.gov/Archives/edgar/data/1382574/000149315224037953/ex3-1.htm)\n\n3.6\n \n[Amended and Restated Bylaws of the Company, as amended through March 24, 2022 (incorporated by reference to Exhibit 3.10 of the Company’s Form 10-K filed on March 26, 2025).](https://www.sec.gov/Archives/edgar/data/1382574/000107878214001329/form10_ex3z1.htm)\n\n4.1\n \n[Certificate of Designation of Series B Preferred Stock (incorporated by reference to Exhibit 3.1 of the Company’s Form 8-K filed on June 26, 2023).](https://www.sec.gov/Archives/edgar/data/1382574/000149315223022532/ex3-1.htm)\n\n4.2\n \n[Certificate of Designation of Preferences, Rights and Limitations of Series C Preferred Stock (incorporated by reference to Exhibit 3.1 of the Company’s Form 8-K filed on October 11, 2023).](https://www.sec.gov/Archives/edgar/data/1382574/000149315223036917/ex3-1.htm)\n\n4.3\n \n[Certificate of Designation of Preference, Rights and Limitations of Series X Non-Voting Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 of the Company’s Form 8-K filed on July 31, 2024).](https://www.sec.gov/Archives/edgar/data/1382574/000149315224029787/ex3-1.htm)\n\n10.1\n \n[Note Purchase Agreement dated April 27, 2026, by and between the Company and Streeterville Capital, LLC (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed on May 1, 2026).](https://www.sec.gov/Archives/edgar/data/1382574/000149315226020931/ex10-1.htm)\n\n10.2\n \n[Secured Promissory Note A-1 dated April 27, 2026, made by the Company in favor of Streeterville Capital, LLC (incorporated by reference to Exhibit 10.2 of the Company’s Form 8-K filed on May 1, 2026).](https://www.sec.gov/Archives/edgar/data/1382574/000149315226020931/ex10-2.htm)\n\n10.3\n \n[Secured Promissory Note B dated April 27, 2026, made by the Company in favor of Streeterville Capital, LLC (incorporated by reference to Exhibit 10.3 of the Company’s Form 8-K filed on May 1, 2026).](https://www.sec.gov/Archives/edgar/data/1382574/000149315226020931/ex10-3.htm)\n\n10.4\n \n[Security Agreement dated April 27, 2026, by and between the Company and Streeterville Capital, LLC (incorporated by reference to Exhibit 10.4 of the Company’s Form 8-K filed on May 1, 2026).](https://www.sec.gov/Archives/edgar/data/1382574/000149315226020931/ex10-4.htm)\n\n10.5\n \n[Security Agreement dated April 27, 2026, by and between Scienture, LLC and Streeterville Capital, LLC (incorporated by reference to Exhibit 10.5 of the Company’s Form 8-K filed on May 1, 2026).](https://www.sec.gov/Archives/edgar/data/1382574/000149315226020931/ex10-5.htm)\n\n10.6\n \n[Intellectual Property Security Agreement dated April 27, 2026, by and between Scienture, LLC and Streeterville Capital, LLC (incorporated by reference to Exhibit 10.6 of the Company’s Form 8-K filed on May 1, 2026).](https://www.sec.gov/Archives/edgar/data/1382574/000149315226020931/ex10-6.htm)\n\n10.7\n \n[Pledge Agreement dated April 27, 2026, by and between the Company and Streeterville Capital, LLC (incorporated by reference to Exhibit 10.7 of the Company’s Form 8-K filed on May 1, 2026).](https://www.sec.gov/Archives/edgar/data/1382574/000149315226020931/ex10-7.htm)\n\n10.8\n \n[Guaranty dated April 27, 2026, made by Scienture, LLC and SCNX Holdings, LLC for the benefit of Streeterville Capital, LLC (incorporated by reference to Exhibit 10.8 of the Company’s Form 8-K filed on May 1, 2026).](https://www.sec.gov/Archives/edgar/data/1382574/000149315226020931/ex10-8.htm)\n\n31.1\n \n[Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex31-1.htm)\n\n31.2\n \n[Certification of Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex31-2.htm)\n\n32.1\n \n[Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex32-1.htm)\n\n32.2\n \n[Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex32-2.htm)\n\n101.INS\n \nInline\nXBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within\nthe Inline XBRL document)\n\n101.SCH\n \nInline\nXBRL Taxonomy Extension Schema Document\n\n101.CAL\n \nInline\nXBRL Taxonomy Extension Calculation Linkbase Document\n\n101.DEF\n \nInline\nXBRL Taxonomy Extension Definition Linkbase Document\n\n101.LAB\n \nInline\nXBRL Taxonomy Extension Label Linkbase Document\n\n101.PRE\n \nInline\nXBRL Taxonomy Extension Presentation Linkbase Document\n\n104\n \nCover\nPage Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).\n\n  \n\n36\n\n[Table of Contents](#toc)\n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by\nthe undersigned thereunto duly authorized.\n\n \n\n \n**SCIENTURE\nHOLDINGS, INC.**\n\n \n \n \n\n \nBy:\n*/s/\nDr. Narasimhan Mani*\n\n \n \nDr.\nNarasimhan Mani\n\n \n \n\nCo-Chief\nExecutive Officer and President\n\n(Principal\nExecutive Officer)\n\n \n \n \n\n \nBy:\n*/s/\nDr. Shankar Hariharan*\n\n \n \nDr.\nShankar Hariharan\n\n \n \n\nCo-Chief\nExecutive Officer and Executive Chairman\n\n(Principal\nExecutive Officer)\n\n \n \n \n\n \nBy:\n\n*/s/\nEric Sherb*\n\n \n \nEric\nSherb\n\n \n \n\nChief\nFinancial Officer\n\n(Principal\nAccounting/Financial Officer)\n\n \n\n \nDate:\nMay\n15, 2026\n\n \n\n37"}